JPH0645545B2 - 吐き気或いは嘔吐抑制用口腔錠剤 - Google Patents

吐き気或いは嘔吐抑制用口腔錠剤

Info

Publication number
JPH0645545B2
JPH0645545B2 JP60229789A JP22978985A JPH0645545B2 JP H0645545 B2 JPH0645545 B2 JP H0645545B2 JP 60229789 A JP60229789 A JP 60229789A JP 22978985 A JP22978985 A JP 22978985A JP H0645545 B2 JPH0645545 B2 JP H0645545B2
Authority
JP
Japan
Prior art keywords
tablets
oral
tablet
prochlorperazine
vomiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60229789A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61112019A (ja
Inventor
サグデン キース
Original Assignee
レキツト アンド コールマン プロダクツ リミテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by レキツト アンド コールマン プロダクツ リミテツド filed Critical レキツト アンド コールマン プロダクツ リミテツド
Publication of JPS61112019A publication Critical patent/JPS61112019A/ja
Publication of JPH0645545B2 publication Critical patent/JPH0645545B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP60229789A 1984-10-16 1985-10-15 吐き気或いは嘔吐抑制用口腔錠剤 Expired - Lifetime JPH0645545B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848426152A GB8426152D0 (en) 1984-10-16 1984-10-16 Medicinal compositions
GB8426152 1984-10-16

Publications (2)

Publication Number Publication Date
JPS61112019A JPS61112019A (ja) 1986-05-30
JPH0645545B2 true JPH0645545B2 (ja) 1994-06-15

Family

ID=10568269

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60229789A Expired - Lifetime JPH0645545B2 (ja) 1984-10-16 1985-10-15 吐き気或いは嘔吐抑制用口腔錠剤

Country Status (13)

Country Link
US (1) US4717723A (en])
EP (1) EP0180364B1 (en])
JP (1) JPH0645545B2 (en])
AU (1) AU577161B2 (en])
CA (1) CA1251735A (en])
DE (1) DE3576276D1 (en])
DK (1) DK165619C (en])
GB (2) GB8426152D0 (en])
GR (1) GR852481B (en])
IE (1) IE58529B1 (en])
NZ (1) NZ213698A (en])
PT (1) PT81311B (en])
ZA (1) ZA857830B (en])

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
GB8608818D0 (en) * 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5112616A (en) * 1988-11-30 1992-05-12 Schering Corporation Fast dissolving buccal tablet
US5002759A (en) * 1989-07-25 1991-03-26 Colgate-Palmolive Company Oligosaccharide inhibition of Streptococcus pyogenes adhesion
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
GB9508463D0 (en) * 1995-04-26 1995-06-14 Link Pharmaceuticals Limited Anti-emetic pharmaceutical compositions
WO1997026865A1 (en) * 1996-01-29 1997-07-31 Edward Mendell Co., Inc. Sustained release excipient
RU2123330C1 (ru) * 1997-04-02 1998-12-20 Фармацевтическая фирма "Здоровье" Способ получения таблетированной формы препарата
IN186245B (en]) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6270790B1 (en) * 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
EP1708686B1 (en) * 2003-12-31 2011-02-16 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US7858121B2 (en) * 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
ATE500821T1 (de) * 2003-12-31 2011-03-15 Cima Labs Inc Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von oxycodon
DE102004003572A1 (de) * 2004-01-23 2005-08-18 Bavarian Nordic A/S Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
GB2433887A (en) * 2006-01-04 2007-07-11 Reckitt Benckiser Healthcare Pack for phenothiazine derivatives
EP2320753B1 (en) * 2008-09-05 2011-12-21 Unilever N.V. Beverages comprising potassium
MX2011012078A (es) * 2009-05-20 2012-03-14 Lingual Consegna Pty Ltd Formulacion terapeutica bucal y/o sublingual.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407486A (en) * 1941-11-21 1946-09-10 Du Pont Veterinary compositions
US3218232A (en) * 1962-11-09 1965-11-16 American Home Prod Method for relieving depression and composition therefor
US3557016A (en) * 1965-10-22 1971-01-19 Kelco Co Heat reversible gel and method for preparing same
US3700451A (en) * 1970-04-06 1972-10-24 Itek Corp Gelable and gelled compositions
US3944427A (en) * 1970-04-06 1976-03-16 Itek Corporation Gelable and gelled compositions
US4038206A (en) * 1976-01-15 1977-07-26 General Mills Chemicals, Inc. Hydroxyalkyl locust bean/xanthomonas hydrophilic colloid blends
US4425337A (en) * 1981-12-30 1984-01-10 Merck & Co., Inc. Adjuvants for rectal delivery of drug
US4559326A (en) * 1985-01-31 1985-12-17 Pfizer Inc. Antiinflammatory compositions and methods

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions

Also Published As

Publication number Publication date
AU4873385A (en) 1986-04-24
AU577161B2 (en) 1988-09-15
US4717723A (en) 1988-01-05
EP0180364A3 (en) 1987-08-19
GB8525175D0 (en) 1985-11-13
IE58529B1 (en) 1993-10-06
DK165619C (da) 1993-06-01
DK470685D0 (da) 1985-10-15
GB8426152D0 (en) 1984-11-21
PT81311A (en) 1985-11-01
GR852481B (en]) 1986-02-14
GB2165451B (en) 1988-07-06
GB2165451A (en) 1986-04-16
PT81311B (pt) 1987-11-30
ZA857830B (en) 1986-05-28
JPS61112019A (ja) 1986-05-30
IE852525L (en) 1986-04-16
NZ213698A (en) 1988-01-08
EP0180364B1 (en) 1990-03-07
DK470685A (da) 1986-04-17
DE3576276D1 (de) 1990-04-12
EP0180364A2 (en) 1986-05-07
DK165619B (da) 1992-12-28
CA1251735A (en) 1989-03-28

Similar Documents

Publication Publication Date Title
JPH0645545B2 (ja) 吐き気或いは嘔吐抑制用口腔錠剤
EP0707478B1 (en) Improved nicotine lozenge
KR100330942B1 (ko) 설하또는협측투여용약학조성물
US20100016448A1 (en) Flashmelt oral dosage formulation
CA2437266C (en) Taste-masked resinate and preparation thereof
US5731338A (en) Controlled release pilocarpine delivery system
HU211592A9 (en) Ranitidine resin adsorbates
CH685978A5 (fr) Comprimes dispersables dans l'eau.
PT1082106E (pt) Comprimido efervescente para administração subligual, bucal e gengival de fentanil
JP2011500505A (ja) オルメサルタンメドキソミル及びアムロジピンの固形製剤
JP2983973B1 (ja) 口腔内速崩壊性固形製剤
RU2150276C1 (ru) Фармацевтическая препаративная форма цефаклора и способ ее получения
EP1549326A1 (fr) Formulation orale seche a visee phlebotonique et vasculoprotectrice pour le traitement de l'insuffisance veineuse, de la fragilite capillaire et de la crise hemorroidaire, sous forme pharmaceutique de comprime a croquer contenant de la diosmine
WO2011136751A2 (en) Water soluble pharmaceutical composition
CA2366845A1 (en) Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained
EP2919744B1 (en) Effervescent tablet
WO1999047172A2 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
JPH07126163A (ja) 制御放出性ピロカルピン送達システム
JPH09501680A (ja) Ｈ▲下２▼−アンタゴニストの経口組成物
JPH11116465A (ja) 迅速溶解性製剤およびその製造法
WO1994001108A1 (en) Controlled release pilocarpine delivery system
RU2125878C1 (ru) Анальгетическое средство
KR0184350B1 (ko) 오메프라졸 구강점막 부착 정제 조성물
JP2024128901A (ja) デスロラタジン固形製剤
EP3127555A1 (en) Solid preparation for coating agent, and film and coated solid preparation formed from same